Human Regulatory T Cells Are Targets for Human Immunodeficiency Virus (HIV) Infection, and Their Susceptibility Differs Depending on the HIV Type 1 Strain

被引:78
作者
Moreno-Fernandez, Maria E. [1 ]
Zapata, Wildeman [1 ,2 ]
Blackard, Jason T. [3 ]
Franchini, Genoveffa [4 ]
Chougnet, Claire A. [1 ]
机构
[1] Univ Cincinnati, Div Mol Immunol, Cincinnati Childrens Hosp, Dept Pediat,Res Fdn,Coll Med, Cincinnati, OH 45229 USA
[2] Univ Antioquia, Grp Inmunovirol, Medellin, Antioquia, Colombia
[3] Univ Cincinnati, Div Digest Dis, Coll Med, Cincinnati, OH 45267 USA
[4] NCI, Anim Models & Retroviral Vaccines Sect, Bethesda, MD 20892 USA
关键词
LONG TERMINAL REPEAT; NF-KAPPA-B; PERIPHERAL-BLOOD; IN-VITRO; CD4(+); FOXP3; DISEASE; INDIVIDUALS; ACTIVATION; EXPRESSION;
D O I
10.1128/JVI.01352-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Regulatory T cells (Treg) are a subpopulation of CD4(+) T cells characterized by the suppressive activity they exert on effector immune responses, including human immunodeficiency virus (HIV)-specific immune responses. Because Treg express CXCR4 and CCR5, they represent potential targets for HIV; however, Treg susceptibility to HIV infection is still unclear. We therefore performed an extensive study of Treg susceptibility to HIV, using lab strains and primary isolates with either CCR5 or CXCR4 tropism. Furthermore, we quantified HIV infection at early and late time points of the virus life cycle. We found that Treg were clearly susceptible to HIV infection. Circulating Treg were not preferentially infected with HIV compared to effector T cells (Teff) in vivo. Conversely, in vitro infection with either CCR5-using (R5) or CXCR4-using (X4) viruses occurred with different dynamics. For instance, HIV infection by R5 viruses (lab strains and primary isolates) resulted in lower levels of infection in Treg compared with Teff at both early and late time points. In contrast, X4 viruses induced higher levels of infection in Treg compared to Teff at early time points, but this difference disappeared at the late time points of the virus life cycle. Our results suggest that the relative susceptibility of Treg to HIV infection compared to Teff varies, depending on both viral and host factors. These variations may play an important role in HIV pathogenesis.
引用
收藏
页码:12925 / 12933
页数:9
相关论文
共 36 条
[31]   Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells:: induction of autoimmune disease by breaking their anergic/suppressive state [J].
Takahashi, T ;
Kuniyasu, Y ;
Toda, M ;
Sakaguchi, N ;
Itoh, M ;
Iwata, M ;
Shimizu, J ;
Sakaguchi, S .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (12) :1969-1980
[32]   Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4 [J].
Takahashi, T ;
Tagami, T ;
Yamazaki, S ;
Uede, T ;
Shimizu, J ;
Sakaguchi, N ;
Mak, TW ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (02) :303-309
[33]   Resting Regulatory CD4 T Cells: A Site of HIV Persistence in Patients on Long-Term Effective Antiretroviral Therapy [J].
Tran, Tu-Anh ;
de Herve, Marie-Ghislaine de Goer ;
Hendel-Chavez, Houria ;
Dembele, Bamory ;
Le Nevot, Emilie ;
Abbed, Karim ;
Pallier, Coralie ;
Goujard, Cecile ;
Gasnault, Jacques ;
Delfraissy, Jean-Francois ;
Balazuc, Anne-Marie ;
Taoufik, Yassine .
PLOS ONE, 2008, 3 (10)
[34]   Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes [J].
Unutmaz, D ;
KewalRamani, VN ;
Marmon, S ;
Littman, DR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (11) :1735-1746
[35]   Cytoplasmic APOBEC3G Restricts Incoming Vif-Positive Human Immunodeficiency Virus Type 1 and Increases Two-Long Terminal Repeat Circle Formation in Activated T-Helper-Subtype Cells [J].
Vetter, Michael L. ;
D'Aquila, Richard T. .
JOURNAL OF VIROLOGY, 2009, 83 (17) :8646-8654
[36]   Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients [J].
Weiss, L ;
Donkova-Petrini, V ;
Caccavelli, L ;
Balbo, M ;
Carbonneil, C ;
Levy, Y .
BLOOD, 2004, 104 (10) :3249-3256